Leonard Sank - Net Worth and Insider Trading
Leonard Sank Net Worth
The estimated net worth of Leonard Sank is at least $1 Million dollars as of 2024-11-13. Leonard Sank is the Director of Oramed Pharmaceuticals Inc and owns about 592,013 shares of Oramed Pharmaceuticals Inc (ORMP) stock worth over $1 Million. Details can be seen in Leonard Sank's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Leonard Sank has not made any transactions after 2019-09-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Leonard Sank
Leonard Sank Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Leonard Sank owns 1 companies in total, including Oramed Pharmaceuticals Inc (ORMP) .
Click here to see the complete history of Leonard Sank’s form 4 insider trades.
Insider Ownership Summary of Leonard Sank
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ORMP | Oramed Pharmaceuticals Inc | 2019-09-09 | director |
Leonard Sank Latest Holdings Summary
Leonard Sank currently owns a total of 1 stock. Leonard Sank owns 592,013 shares of Oramed Pharmaceuticals Inc (ORMP) as of September 9, 2019, with a value of $1 Million.
Latest Holdings of Leonard Sank
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ORMP | Oramed Pharmaceuticals Inc | 2019-09-09 | 592,013 | 2.34 | 1,385,310 |
Holding Weightings of Leonard Sank
Leonard Sank Form 4 Trading Tracker
According to the SEC Form 4 filings, Leonard Sank has made a total of 0 transactions in Oramed Pharmaceuticals Inc (ORMP) over the past 5 years. The most-recent trade in Oramed Pharmaceuticals Inc is the acquisition of 25,000 shares on September 9, 2019, which cost Leonard Sank around $73,000.
Insider Trading History of Leonard Sank
- 1
Leonard Sank Trading Performance
GuruFocus tracks the stock performance after each of Leonard Sank's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Leonard Sank is 15.93%. GuruFocus also compares Leonard Sank's trading performance to market benchmark return within the same time period. The performance of stocks bought by Leonard Sank within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Leonard Sank's insider trading performs compared to the benchmark.
Performance of Leonard Sank
Leonard Sank Ownership Network
Ownership Network List of Leonard Sank
Ownership Network Relation of Leonard Sank
Leonard Sank Owned Company Details
What does Oramed Pharmaceuticals Inc do?
Who are the key executives at Oramed Pharmaceuticals Inc?
Leonard Sank is the director of Oramed Pharmaceuticals Inc. Other key executives at Oramed Pharmaceuticals Inc include director & 10 percent owner Nadav Kidron , Chief Commercial Officer Michael Rabinowitz , and Chief Financial Officer David Silberman .
Oramed Pharmaceuticals Inc (ORMP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Oramed Pharmaceuticals Inc (ORMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oramed Pharmaceuticals Inc (ORMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Oramed Pharmaceuticals Inc (ORMP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oramed Pharmaceuticals Inc Insider Transactions
Leonard Sank Mailing Address
Above is the net worth, insider trading, and ownership report for Leonard Sank. You might contact Leonard Sank via mailing address: 3 Blair Road, Cape Town T3 8005.